Angeline Ginzac
Angeline Ginzac is an expert in Oncology at Centre Jean Perrin (France). Angeline Ginzac has authored 37 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 4 of them ongoing. SLR score: 220 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Radiotherapy - Palliative Medicine - Geriatrics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2015 - 2026
Number : 37
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas NCT07178847 — cells, dna, complementary, blood, blood specimen collection, carcinoma, squamous cell, neoplasms, biomarkers, squamous cell carcinoma of head and neck, chemoradiotherapy, neoplasm, residual, carcinoma, head, neck | N/A | Recruiting | 2025 |
| Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma NCT06550674 — genes, blood, melanoma, neoplasms, diagnosis, thyroid neoplasms, research, exome, history, wounds and injuries, uveal melanoma | N/A | Recruiting | 2024 |
| Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer NCT05710679 — radiotherapy, blood, blood specimen collection, tomography, neoplasms, predictive value of tests, positron emission tomography computed tomography, fluorodeoxyglucose f18, chemoradiotherapy, head and neck neoplasms, therapeutics, carcinoma, head, neck | N/A | Recruiting | 2024 |
| Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer NCT04133077 — serology, blood, breast neoplasms, neoplasms, breast, neoadjuvant therapy, therapeutics, heterografts, prospective studies, female | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map